Aia Group LTD Vertex Pharmaceuticals Inc Transaction History

Aia Group LTD

$3.67 Billion
Q3 2024

A detailed history of Aia Group LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aia Group LTD holds 30,786 shares of VRTX stock, worth $15.5 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

30,786

Previous 29,264 5.2%

Holding current value

$15.5 Million

Previous $13.7 Million 4.38%

% of portfolio

0.39%

Previous 0.42%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$460.0 - $505.78 $700,120 - $769,797	1,522 Added 5.2%	30,786 $14.3 Million
Q2 2024 Jul 31, 2024	BUY	$392.81 - $485.53 $1.92 Million - $2.38 Million	4,898 Added 20.1%	29,264 $13.7 Million
Q1 2024 May 06, 2024	BUY	$407.69 - $446.08 $2.35 Million - $2.57 Million	5,766 Added 31.0%	24,366 $10.2 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $518,616 - $620,948	1,512 Added 8.85%	18,600 $7.57 Million
Q3 2023 Nov 01, 2023	BUY	$338.18 - $362.46 $106,188 - $113,812	314 Added 1.87%	17,088 $5.94 Million
Q2 2023 Jul 28, 2023	BUY	$314.42 - $351.91 $2.82 Million - $3.16 Million	8,977 Added 115.13%	16,774 $5.9 Million
Q1 2023 Apr 28, 2023	BUY	$283.23 - $323.1 $25,207 - $28,755	89 Added 1.15%	7,797 $2.46 Million
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $550,088 - $618,849	-1,925 Reduced 19.98%	7,708 $2.23 Million
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $518,360 - $578,368	-1,893 Reduced 16.42%	9,633 $2.79 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $224,386 - $279,385	-955 Reduced 7.65%	11,526 $3.25 Million
Q1 2022 May 06, 2022	BUY	$221.42 - $260.97 $2.08 Million - $2.45 Million	9,397 Added 304.7%	12,481 $3.26 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $527,666 - $666,104	-2,981 Reduced 49.15%	3,084 $677,000
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $1.1 Million - $1.23 Million	6,065 New	6,065 $1.1 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $365,804 - $426,394	-1,767 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $365,786 - $487,851	1,767 New	1,767 $373,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account